Eddit

Version vom 21. Mai 2020, 11:41 Uhr

• Further reading
• Unproven ideas
• Reviews on covid19 disease

32335367 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
32333222 ä. The genetic sequence, origin, and diagnosis of SARS-CoV-2
32269085 ä. Pathogenesis of COVID-19 from a cell biologic perspective
32141570 2020. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV
32141569 2020. COVID-19 (Novel Coronavirus 2019) - recent trends
32329877 2020. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options
32317050 2020. Coronavirus disease (COVID-19): a scoping review
32306751 2020. Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions

• Research tools

32142596 2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS
32187834 2020. ..COVID19: Cytometry and the New Challenge for Global Health
32270412 ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2

• Structure of covid19

32265007 2020. Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe
32210741 2020. Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target

• Target binding and uptake

32220422 2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
32336612 ä. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
32210742 2020. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis

• Cytopathic effects
• Secretion and shedding

32271376 ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19

• Innate sensing
• Immunology

32348472 ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?

• Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome

• Microvascular
• Early symptoms
• Systemic disease, any manifestations

32160148 2020. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China
32343223 2020. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient
32298228 2020. Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19
32345526 ä. Factors associated with mortality in patients with COVID-19 A quantitative evidence synthesis of clinical and laboratory data
32290901 2020. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020

• ARDS

• Pulmonary embolism, coagulation

32334995 2020. Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia
32303472 ä. Acute pulmonary embolism in a patient with COVID-19 pneumonia
32348233 2020. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease
32227120 ä. Acute pulmonary embolism and COVID-19 pneumonia: a random association?
32338707 ä. Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient

• Hematology
• Heart

32363381 ä. Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?
32227076 ä. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19
32196087 ä. SARS-CoV2: should inhibitors of the renin?angiotensin system be withdrawn in patients with COVID-19?
32267502 ä. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection
32267494 ä. CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic
32285920 ä. Transient complete heart block in a patient with critical COVID-19
32285915 ä. Typical takotsubo syndrome triggered by SARS-CoV-2 infection
32338706 ä. Myocarditis revealing COVID-19 infection in a young patient
32282027 ä. COVID-19-related myocarditis in a 21-year-old female patient
32359887 ä. SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade

• Neurology, ophthalmology, orl

32283980 2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms
32269598 2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
32370982 ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review
32253535 ä. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
32328771 ä. The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19
32303881 ä. Possible link between anosmia and COVID-19: sniffing out the truth
32309267 2020. Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered?
32329813 2020. Defining the burden of olfactory dysfunction in COVID-19 patients

• Dermatology
• Gastroenterology, hepatology

32309266 2020. Abdominal Pain: A Real Challenge in Novel COVID-19 Infection

• Kidney, urology==

32299479 2020. Acute kidney injury in SARS-CoV-2 infected patients
32197060 2020. Rhabdomyolysis as Potential Late Complication Associated with COVID-19

• Pathobiology

32294179 ä. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications
32293672 ä. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
32350105 ä. Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection
32341103 2020. Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review

• Disease Models

32215622 ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
32378471 2020. Animal models for emerging coronavirus: progress and new insights

• Similar diseases and pathomechanisms

31859605 2020. Genetic manipulation of porcine deltacoronavirus reveals insights into NS6 and NS7 functions: a novel strategy for vaccine design
32186278 2020. Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19)

• Diagnosis (Laboratory)

32270412 ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2
32342252 ä. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
32329811 2020. The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-nCov
32156329 2020. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system
32209163 2020. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
32156330 2020. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020
31992387 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
32046815 2020. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020
32347204 2020. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
32290902 2020. An alternative workflow for molecular detection of SARS-CoV-2 escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020
32290904 2020. Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020
32156101 2020. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)

• Diagnosis (Lung CT, Sonography)

32294704 ä. Structured thoracic computed tomography report for COVID-19 pandemic
32374802 ä. The halo sign as a chest computed tomography finding of COVID-19
32241244 2020. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019
32285222 ä. Three unsuspected CT diagnoses of COVID-19
32285028 2020. Lung Changes on Chest CT During 2019 Novel Coronavirus (COVID-19) Pneumonia
32337662 ä. Classification of COVID-19 patients from chest CT images using multi-objective differential evolution?based convolutional neural networks
32107577 ä. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2
32088847 ä. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases
32198615 ä. The potential added value of FDG PET/CT for COVID-19 pneumonia
32166511 ä. 18F-FDG PET/CT and COVID-19
32350559 ä. Is there a role for lung perfusion 99mTc -MAA SPECT/CT to rule out pulmonary embolism in COVID-19 patients with contraindications for iodine contrast?
32246209 ä. The indispensable role of chest CT in the detection of coronavirus disease 2019 (COVID-19)
32342191 ä. FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients
32335706 ä. CT, 18F FDG-PET/CT and clinical findings before and during early Covid-19 onset in a patient affected by vascular tumour
32333071 ä. A case of COVID-19 lung infection first detected by 18F FDG PET-CT
32303786 ä. PET imaging of COVID-19: the target and the number
32335426 ä. Imaging of Coronavirus Disease 2019: A Chinese Expert Consensus Statement
32193037 2020. CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity
32199142 2020. Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings
32229322 2020. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?
32240913 2020. High-resolution computed tomography manifestations of COVID-19 infections in patients of different ages
32334369 2020. Serial CT features in discharged COVID-19 patients with positive RT-PCR re-test
32289051 2020. COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review
32325282 2020. Chest CT findings of COVID-19 pneumonia by duration of symptoms
32367422 ä. Interpretation of CT signs of 2019 novel coronavirus (COVID-19) pneumonia
32367421 ä. Incidentally discovered COVID-19 pneumonia: the role of diagnostic imaging
32367418 ä. Imaging features and evolution on CT in 100 COVID-19 pneumonia patients in Wuhan, China
32215691 ä. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19)
32025790 ä. Imaging changes in patients with 2019-nCov
32211963 ä. Coronavirus disease 2019: initial chest CT findings
32193638 ä. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review
32193637 ä. Recommendation of low-dose CT in the detection and management of COVID-2019
32072255 ä. Outbreak of novel coronavirus (COVID-19): What is the role of radiologists?
32055945 ä. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China
32270314 ä. What can European radiologists learn from the outbreak of COVID-19 in China? A discussion with a radiologist from Wuhan
32346790 2020. Coronavirus disease 2019 (COVID-19) imaging reporting and data system (COVID-RADS) and common lexicon: a proposal based on the imaging data of 37 studies
32323011 ä. Characteristic CT findings distinguishing 2019 novel coronavirus disease (COVID-19) from influenza pneumonia
32314058 ä. COVID-19 patients and the radiology department ? advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI)
32300971 ä. A diagnostic model for coronavirus disease 2019 (COVID-19) based on radiological semantic and clinical features: a multi-center study
32296940 ä. The role of imaging in 2019 novel coronavirus pneumonia (COVID-19)
32291502 ä. Evolution of CT findings in patients with mild COVID-19 pneumonia
32291501 ä. CT features of novel coronavirus pneumonia (COVID-19) in children
32279115 ä. CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city
32217649 2020. Clinical and CT features of early stage patients with COVID-19: a retrospective analysis of imported cases in Shanghai, China
32196627 2020. Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak

• Diagnosis (other modalities)

32276598 2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia

• Respiration mgmt

32371555 2020. Utility of extracorporeal membrane oxygenation in COVID-19
32357995 2020. Tracheal intubation in patients with COVID-19
32326959 2020. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients
C7156900 2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series
32322959 ä. Tracheostomy in the COVID-19 pandemic
32314050 ä. Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic
32299867 2020. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion
32271455 2020. Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report

• Clinical guidelines and advice

32306118 ä. COVID-19 in otolaryngologist practice: a review of current knowledge
32352517 ä. Anticoagulation in COVID-19
32265307 ä. Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches
32341111 2020. Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers
32269090 ä. Managing the supportive care needs of those affected by COVID-19
32329880 2020. Short Report - Medical nutrition therapy for critically ill patients with COVID-19

• Risk and special populations

32232395 ä. Initial COVID-19 affecting cardiac patients in China
32324223 ä. Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence
32324222 ä. Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19
32236478 ä. Speculation is not evidence: antihypertensive therapy and COVID-19
32286607 ä. Might renin?angiotensin system blockers play a role in the COVID-19 pandemic?
32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment
32328850 ä. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening
32322046 ä. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China
32296994 ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32345527 ä. Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence
32307204 ä. Intrapartum care of women with COVID-19: A practical approach
32278619 ä. The novel coronavirus (2019-nCoV) in pregnancy: What we need to know
32217650 2020. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
32269087 ä. Novel Coronavirus Infection in Newborn Babies Under 28 Days in China
32269088 2020. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
32341104 2020. Cardiovascular comorbidity and its impact on patients with Covid-19
32350104 ä. COVID-19 and Nicotine as a Mediator of ACE-2
32341101 2020. COVID-19 and Smoking Is Nicotine the Hidden Link?
32312864 ä. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019
32279905 ä. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection
32284245 ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??
32317180 ä. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China

• Case reports

32241316 ä. Case Report on Early Diagnosis of COVID-19
32343659 2020. A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic
32160149 2020. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States

32221725 ä. Brief report of the first cured 2019-nCoV pneumonia patient in West China Hospital

• Case series

32337324 2020. The Data set for Patient Information Based Algorithm to Predict Mortality Cause by COVID-19
32267826 2020. Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand
32208917 2020. The different clinical characteristics of corona virus disease cases between children and their families in China ? the character of children with COVID-19
32269086 ä. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China
32139464 ä. The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China
32271459 2020. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha
32347201 2020. Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020

• The morbid survivor

32329589 2020. Rehabilitation management of patients with COVID-19 Lessons learned from the first experiences in China
32316718 2020. Systematic rapid "living" review on rehabilitation needs due to covid-19: update to march 31st 2020
32293817 2020. Rehabilitation and respiratory management in the acute and early post-acute phase "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency
32217657 ä. Urgent need of a management plan for survivors of COVID-19

• Trials

C7102592 ä. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID)

• Candidate Compounds Covid19

32363880 2020. Medical treatment options for COVID-19
32372695 2020. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
32347925 ä. Statin therapy in COVID-19 infection
32347923 ä. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety
32337546 ä. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?
32282032 ä. Neprilysin inhibitor?angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients
32285293 ä. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV
C7129866 ä. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19
32341100 2020. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
32265310 ä. Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19
32271462 2020. Inositol and pulmonary function Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?
32271456 2020. Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019
32271454 2020. Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19
32329881 2020. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience
32329879 2020. (Naturlal products: )An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections
32327396 ä. COVID-19 and Bacillus Calmette-Guerin: What is the Link?
32279655 2020. Can Hepatitis A Vaccine Provide Protection Against COVID-19?

• Biophysics of aerosols
• Other routes of infection

32241022 ä. SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection
32297915 ä. Comment of the potential risks of sexual and vertical transmission of Covid-19 infection
32243255 2020. Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations
32342724 2020. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient
32336661 ä. Is there evidence of intra-uterine vertical transmission potential of COVID-19 infection in samples tested by quantitative RT-PCR?

• Passive protective equipment

32324531 2020. The Practice of Wearing Surgical Masks during the COVID-19 Pandemic
32284092 2020. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols
32282025 ä. Donning and doffing of personal protective equipment (PPE) for angiography during the COVID-19 crisis
32248146 2020. Protecting healthcare workers from SARS-CoV-2 infection: practical indications
32350103 ä. Universal use of face masks for success against COVID-19: evidence and implications for prevention policies
32271461 2020. COVID-19: emerging protective measures
32329812 2020. Just one more hygiene practice in COVID-19

• Running your hospital

32228737 ä. COVID-19 disease emergency operational instructions for Mental Health Departments issued by the Italian Society of Epidemiological Psychiatry
32303485 ä. French consensus on management of head and neck cancer surgery during COVID-19 pandemic
32338298 ä. The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic
32232396 ä. Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak
32361812 ä. Mental health treatment online during the COVID-19 outbreak
32338764 ä. A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience
32286606 ä. Priorities for Cath labs in the COVID-19 tsunami: Roberto Ferrari and co-authors present a procedure to follow subsequent to the outbreak in Italy
32320040 ä. Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective
32242891 ä. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel
32285027 2020. Breast Cancer Diagnosis, Treatment and Follow-Up During COVID-19 Pandemic
32285026 2020. Sars-CoV-2 (COVID-19) Outbreak and Breast Cancer Surgery in Turkey
32305011 2020. Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?related disease pandemic
32294611 2020. A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19?positive patients with cancer
32361628 ä. Lessons from the COVID-19 pandemic ? will virtual patient management reshape uro-oncology in Germany?
32302754 2020. Managing patients with cancer in the COVID-19 era
32301984 ä. The COVID-19 outbreak and its impact on hospitals in Italy: the model of cardiac surgery
32301976 ä. Management of elective aortic valve replacement over the long term in the era of COVID-19
32243318 2020. COVID-19: emergency medicine perspectives from Hong Kong
32243317 2020. European Society For Emergency Medicine position paper on emergency medical systems? response to COVID-19
32229768 2020. COVID-19: response plan for International Medical Assistance companies
32224710 2020. How emergency departments prepare for virus disease outbreaks like COVID-19
32205709 2020. The challenge of emergency medicine facing the COVID-19 outbreak
32345851 2020. The emergency department in the COVID-19 era Who are we missing?
32362361 ä. Non-SARS CoV2 positive critical patients: sons of a lesser God?
32215677 ä. Suggestions for safety and protection control in Department of Nuclear Medicine during the outbreak of COVID-19
32232520 ä. Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020?
32318782 ä. Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units
32296886 ä. COVID-19 pandemic: guidance for nuclear medicine departments
32296884 ä. Nuclear medicine in responding to global pandemic COVID-19?American College of Nuclear Medicine member experience
32303841 ä. Lead the way or leave the way: leading a Department of Orthopedics through the COVID-19 pandemic
32225137 2020. Facing in real time the challenges of the Covid-19 epidemic for rehabilitation
32175719 2020. Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine (PRM) physicians activities in Italy An official document of the Italian PRM Society (SIMFER)
32327266 ä. Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it?
32264667 2020. First impact on services and their preparation "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency
32329593 2020. Telemedicine from research to practice during the pandemic "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency
32329592 2020. Organization of acute patients transfer to rehabilitation services during COVID-19 crisis
32329590 2020. Impact of coronavirus disease 2019 (covid-19) outbreak on rehabilitation services and physical medicine and rehabilitation (PM&R) physicians activities: perspectives from the Spanish experience
32329591 2020. Covid-19 and child disabilities: whom to protect and how
32293816 2020. The impact of covid-19 on rehabilitation services and activities Letter to the editor in response to official document of SIMFER
32313348 ä. Nosocomial infections in psychiatric hospitals during the new coronavirus pneumonia outbreak
32344294 2020. Radiology department strategies to protect radiologic technologists against COVID19: Experience from Wuhan
32336627 ä. The need of COVID19 free hospitals to maintain cancer care
32359919 ä. COVID-19: The European institute of oncology as a hub centre for breast cancer surgery during the pandemic in Milan (Lombardy region, northern Italy) - A screenshot of the first month
32371040 ä. Rationalizing breast cancer surgery during the COVID-19 pandemic
32362468 ä. Cancer surgery in a time of COVID-19: Many questions, few certainties
32371041 ä. Cancer care under the outbreak of COVID-19
32336625 ä. Coronavirus outbreak: Reorganising the breast unit during a pandemic
32359918 2020. Management of Gynaecological oncology diseases during COVID-19 global pandemic
32331984 ä. Surgical management of bone and soft tissue sarcomas and skeletal metastases during the COVID-19 pandemic
32312591 ä. Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology
32347329 ä. Surgical management of suspected or confirmed SARS-CoV-2 (COVID-19)-positive patients: a model stemming from the experience at Level III Hospital in Emilia-Romagna, Italy
32313969 ä. Personal reflections of an emergency general surgeon on the COVID-19 pandemic
32303798 ä. European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID-19 infection
32303451 ä. The Need of Research Initiatives Amidst and After the Covid-19 Pandemic: A Message from the Editors of the European Journal of Vascular and Endovascular Surgery
32307223 ä. Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: policy and service recommendations
32234102 ä. The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
32328761 ä. Adapting to a new normal? 5 key operational principles for a radiology service facing the COVID-19 pandemic
32356161 ä. Important lessons for infection control in radiology departments during the COVID-19 pandemic
32318843 ä. The Radiology Department during the COVID-19 pandemic: a challenging, radical change
32300968 ä. Prevention and control measures in radiology department for COVID-19
32198275 2020. More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
32312865 ä. Covid19: minimising risk to healthcare workers during aerosol producing respiratory therapy using an innovative constant flow canopy
32273180 ä. What Does COVID-19 Mean for the Pathology-Urology Interaction?
32279903 ä. Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic
32329810 2020. In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention?
32362496 ä. Urolithiasis Practice Patterns Following the COVID-19 Pandemic: Overview from the EULIS Collaborative Research Working Group
32362498 ä. Telemedicine Online Visits in Urology During the COVID-19 Pandemic?Potential, Risk Factors, and Patients? Perspective
32360050 2020. VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic
32349934 ä. The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead?
32349928 ä. Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guerin for High-risk Non?muscle-invasive Bladder Cancer During the COVID-19 Pandemic
32349936 ä. Balancing the Effects of COVID-19 Against Potential Progression and Mortality in High-risk Prostate Cancer
32349933 ä. Widespread Postponement of Functional Urology Cases During the COVID-19 Pandemic: Rationale, Potential Pitfalls, and Future Consequences
32345522 ä. COVID-19: Importance of the Awareness of the Clinical Syndrome by Urologists
32349932 ä. Surgical Volume, Safety, Drug Administration, and Clinical Trials During COVID-19: Single-center Experience in Shanghai, China
32345523 ä. The Shifting Landscape of Genitourinary Oncology During the COVID-19 Pandemic and how Italian Oncologists Reacted: Results from a National Survey
32312544 ä. Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic
32334884 ä. Traditional and Virtual Congress Meetings During the COVID-19 Pandemic and the Post-COVID-19 Era: Is it Time to Change the Paradigm?
32331707 ä. Impact of the COVID-19 Pandemic on Paediatric Urology Practice in Europe: A Reflection from the European Association of Urology Young Academic Urologists
32303384 ä. Endourological Stone Management in the Era of the COVID-19
32336644 ä. Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic
32307215 ä. Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres
32372754 2020. Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020
32265003 2020. Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020

• Mental aspects of health professionals

32342698 ä. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic
32346406 2020. COVID-19 pandemic and its impact on mental health of healthcare professionals

• Socio-psychiatric aspects of the status hygienicus

32363492 ä. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19
32371988 ä. COVID-19 pandemic: the effects of quarantine on cardiovascular risk
32335765 ä. Humanistic Epidemiology: Love in the time of cholera, COVID-19 and other outbreaks
32317197 ä. Health anxiety and behavioural changes of pregnant women during the COVID-19 pandemic

• Avoiding clinical medicine in other diseases

32339092 2020. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore
32339091 2020. Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan
32297932 ä. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage
32348457 ä. Where have the STEMIs gone during COVID-19 lockdown?
32318915 ä. Vaccine confidence in the time of COVID-19
32289789 ä. The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era

• Occupational medicine, workplace security and status hygienicus
• Economic aspects of the status hygienicus
• Educational aspects of the status hygienicus
• Host, vector, one health, atmospheric aspects

C7151430 ä. Airborne transmission of SARS-CoV-2: the world should face the reality
32363409 2020. SARS-CoV-2 spread in Northern Italy: what about the pollution role?
32283458 2020. COVID-19 as a factor influencing air pollution?
32268945 ä. Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy??
32361082 2020. Food safety issues related to wildlife have not been taken seriously from SARS to COVID-19
32353790 2020. Biomass use and COVID-19: A novel concern
32330766 ä. Is temperature reducing the transmission of COVID-19 ?
32202420 ä. An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19)

32367256 ä. Nuclear medicine services after COVID-19: gearing up back to normality

• Origin of Covid19

32315281 2020. Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2
32315626 2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
32148173 2020. Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination
32102621 2020. No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2
32056509 2020. HIV-1 did not contribute to the 2019-nCoV genome

• Remission, recurrence and persistence

32183934 2020. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020

• Epidemiology

32323978 ä. Letter to the Editor: Wastewater-Based Epidemiology Can Overcome Representativeness and Stigma Issues Related to COVID-19
32202421 ä. Can a Paper-Based Device Trace COVID-19 Sources with Wastewater-Based Epidemiology?
32311865 2020. Prevention of exposure and dispersion of COVID-19 using air purifiers: challenges and concerns
32375455 2020. Prediction of COVID-19 transmission dynamics using a mathematical model considering behavior changes in Korea
32345002 2020. Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak
32345000 2020. Urgent appeal to minimize community health impacts of COVID-19
32345001 2020. Recommendations to the government following the declaration of COVID-19 pandemic
32344999 2020. Preparedness and response to community spread of COVID-19 governmental and national recommendations for COVID-19 by the Pan-Academic Action Committee
32344998 2020. Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak
32344997 2020. Professional academic organizations on infectious disease Joint Statement on COVID-19
32192278 2020. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak
32164053 2020. Estimating the reproductive number and the outbreak size of COVID-19 in Korea
32035431 2020. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea
32023775 2020. An interim review of the epidemiological characteristics of 2019 novel coronavirus
32202489 ä. Risk of COVID-19 importation to the Pacific islands through global air travel
32100667 ä. Passengers destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America
32242790 ä. The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020
32373189 2020. Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
32352515 ä. The battle against COVID-19: mortality in Italy
32255475 ä. Denominator matters in estimating COVID-19 mortality rates
32255476 ä. COVID-19 experience in Bergamo, Italy
32255477 ä. Strategies to control COVID-19 and future pandemics in Africa and around the globe
32352314 2020. The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions
32347745 ä. Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds
32003000 2020. The novel Chinese coronavirus (2019?nCoV) infections: Challenges for fighting the storm
32270413 ä. A family cluster of severe acute respiratory syndrome coronavirus 2 infections
32291542 ä. The epidemiology and clinical information about COVID-19
32306149 ä. Covid-19 epidemic in Italy: evolution, projections and impact of government measures
32318914 ä. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
32328991 ä. COVID-19 and the need of targeted inverse quarantine
32309108 2020. Mathematical prediction of the time evolution of the COVID-19 pandemic in Italy by a Gauss error function and Monte Carlo simulations
32366488 2020. Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China
32269084 2020. No association of COVID-19 transmission with temperature or UV radiation in Chinese cities
32299861 2020. The influence of preventive strategies on the COVID-2019 epidemic in Shenzhen, China
32139462 ä. Epidemiological characteristics of 2019-ncoV infections in Shaanxi, China by February 8, 2020
32271458 2020. A classifier prediction model to predict the status of Coronavirus COVID-19 patients in South Korea
32329878 2020. Deep thought of COVID-19 based on Diamond Princess s quarantine and home quarantine
32329814 2020. Quarantine hospitals are essential for COVID-19 contention
32234121 2020. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020
32234119 2020. Updated rapid risk assessment from ECDC on coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK
32234117 2020. Potential short-term outcome of an uncontrolled COVID-19 epidemic in Lombardy, Italy, February to March 2020
32234116 2020. Coronavirus disease (COVID-19) Community Testing Team in Scotland: A 14-day review, 6 to 20 February 2020
32234115 2020. Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020
32209164 2020. Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020
32186277 2020. Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
32183937 2020. Updated rapid risk assessment from ECDC on the novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK
32183935 2020. Retrospective analysis of the possibility of predicting the COVID-19 outbreak from Internet searches and social media data, China, 2020
32183930 2020. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020
32156332 2020. Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020
32156331 2020. Updated rapid risk assessment from ECDC on the outbreak of COVID-19: increased transmission globally
32156327 2020. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
32019669 2020. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020
32019667 2020. Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020
31992388 2020. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020
32127126 2020. Latest assessment on COVID-19 from the European Centre for Disease Prevention and Control (ECDC)
32127124 2020. Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020
32070466 2020. Latest updates on COVID-19 from the European Centre for Disease Prevention and Control
32070465 2020. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020
32046819 2020. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20?28 January 2020
32046816 2020. Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)
32046814 2020. Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak
32019636 2020. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern
32372756 2020. Letter to the editor: Evidence on school closure and children?s social contact: useful for coronavirus disease (COVID-19)?
32372755 2020. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020
32372753 2020. Temporal rise in the proportion of younger adults and older adolescents among coronavirus disease (COVID-19) cases following the introduction of physical distancing measures, Germany, March to April 2020
32347198 2020. Epidemiological characteristics of the first 53 laboratory-confirmed cases of COVID-19 epidemic in Hong Kong, 13 February 2020
32347200 2020. Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020
32317053 2020. SARS-CoV2 infection and primary school closure
32290905 2020. A hundred days into the coronavirus disease (COVID-19) pandemic
32317051 2020. Potential lethal outbreak of coronavirus disease (COVID-19) among the elderly in retirement homes and long-term facilities, France, March 2020
32265005 2020. Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020
32265008 2020. Understanding coronavirus disease (COVID-19) risk perceptions among the public to enhance risk communication efforts: a practical approach for outbreaks, Finland, February 2020

• Failure of politics and public health guidance

32246996 ä. The SARS-CoV-2 epidemic: how the Italian public is being informed
32292239 2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis
32252845 ä. Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 Epidemic in France
32224712 2020. COVID-19, a UK perspective
32271457 2020. Mask crisis during the COVID-19 outbreak

• Failure of executive measures
• Political abuse of Covid19

C7152572 ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter
32241328 ä. Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January?February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users
32332201 2020. Infodemic and the spread of fake news in the COVID-19-era

• Lost people
• Lost civilization

32345850 2020. Collateral damage of the COVID-19 outbreak: expression of concern

• History of covid19 exploration
• Current state of coviki.org
• PubMed selected papers unsorted to be listed in contents topics
• coviki state of development
• misc.

32253375 ä. Nutritional management in hospital setting during SARS-CoV-2 pandemic: a real-life experience
32313188 ä. Nutrition amid the COVID-19 pandemic: a multi-level framework for action
32286533 ä. Nutritional recommendations for CoVID-19 quarantine
32293675 ä. Key words to be adopted for COVID-19 research: A return to simple, large, randomized trials
32362362 ä. COVID-19: Timing is Important
32361966 ä. A safe flight for children through COVID-19 disaster: keeping our mind open!
32362487 ä. New Data and the Covid-19 Pandemic Mandate a Rethink of Antiplatelet Strategies in Patients With TIA or Minor Stroke Associated With Atherosclerotic Carotid Stenosis
32271460 2020. Coronavirus disease 2019: a bibliometric analysis and review
32196628 2020. Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2 Would a rose by another name smell as sweet?
32141586 2020. Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches?
31992390 2020. Note from the editors: novel coronavirus (2019-nCoV)
32127122 2020. Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2
32127123 2020. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020
32279654 2020. COVID-19 UPDATE

• from the ads
• covid19 antibodies, proteins & reagents
• 700 kinsse assays